文献速递主动脉疾病

结缔组织病患者开放胸主动脉及胸腹主动脉修复术的结果

Editor's Choice - Open Thoracic and Thoraco-abdominal Aortic Repair in Patients with Connective Tissue Disease.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-09-13

这项回顾性单中心研究分析了65例结缔组织病患者接受的72次开放复杂主动脉修复手术,中位年龄41岁,86%曾接受过主动脉修复。院内死亡率为14%,截瘫/轻瘫发生率分别为2%和5%,1年生存率80%,总体生存率75%。多变量分析显示手术时间超过7小时是死亡率增加的独立预测因素。

要点

  • 结缔组织病患者开放主动脉修复院内死亡率14%,主要死因为出血和神经并发症。
  • 手术时间超过7小时是死亡率增加的独立预测因素(p=.006)。
  • 开放修复远期耐久,再干预豁免率85%,但应限于专科中心开展。

核心结论

  • 开放胸主动脉及胸腹主动脉修复是结缔组织病患者的耐久性治疗,但风险相关,应限于专科中心开展。
  • 如条件允许,应优先采用分期手术以缩短手术时间。

研究设计与样本

  • 回顾性跨境单中心研究,2000年2月至2016年4月对65例结缔组织病患者(41例男性,中位年龄41岁,范围19-70岁)实施了72次主动脉手术。
  • 开放手术包括主动脉弓修整1例(1%)、降胸主动脉修复11例(15%)、TAAA I型12例(17%)、II型29例(40%)、III型12例(17%)、IV型5例(7%);急诊手术8例(11%)。
  • 同期行升主动脉修复2例(3%)、主动脉弓修复8例(11%);分期手术7例(10%)。
  • 中位随访42个月(0.5-180个月)。

主要发现

  • 院内死亡9例(14%),死因为出血(3/9)、神经系统(3/9)、心脏(2/9)和肺部(1/9)并发症。
  • 截瘫1例(2%),轻瘫3例(5%);7例(11%)需要临时透析,无永久透析。
  • 主要并发症包括因出血或血肿再次手术(20/65)、脓毒症(10/65)、心肌梗死/严重心律失常(2/65)、卒中(2/65),以及多器官衰竭、腹腔间隔室综合征、肠系膜和外周缺血(各1/65)。
  • 多变量分析确定手术时间>7小时为死亡率增加的独立预测因素(p=.006)。
  • 再干预豁免率85%,1年生存率80%,总体生存率75%。

临床怎么用

  • 结缔组织病患者开放复杂主动脉修复风险较高,应仅在具备相应经验的专科中心开展。
  • 术前规划应尽量采用分期手术策略以缩短单次手术时间。
  • 术后需密切监测出血、神经并发症及肾功能,因院内死亡和并发症发生率较高。

局限性

  • 回顾性单中心研究,样本量有限(65例患者,72次手术)。
  • 跨越16年时间,手术技术和围手术期管理可能发生变化。
  • 缺乏非结缔组织病对照组,无法直接比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: The aim is to present current results of open complex aortic repair in patients with connective tissue disease (CTD). METHODS: This was a retrospective cross-border, single centre study. From February 2000 to April 2016 72 aortic operations were performed on 65 patients with CTD (41 male, median age 41 years [range 19-70 years]). Fifty-six patients (86%) underwent at least one previous aortic repair (71 open, four endovascular), including 33 patients (51%) operated before at the site of the procedure reported here. The open procedures, counting eight emergency operations (11%), included aortic arch revision (n = 1; 1%), descending thoracic aortic repair (n = 11; 15%), TAAA type I repair (n = 12; 17%), type II repair (n = 29; 40%), type III repair (n = 12; 17%), and type IV repair (n = 5; 7%). Simultaneous repair of the ascending aorta and/or the aortic arch was performed in two (3%) and eight cases (11%), respectively. Seven patients (10%) underwent staged procedures. Median follow-up was 42 months (0.5-180 months). RESULTS: The in hospital mortality was 14% (n = 9) as a result of haemorrhage (n = 3/9), neurological (n = 3/9), cardiac (n = 2/9), and pulmonary (n = 1/9) complications. Paraplegia and paraparesis occurred in one (2%) and three patients (5%), respectively. Seven patients (11%) required temporary dialysis; none needed permanent dialysis. Major complications were revision surgery for bleeding or haematoma (n = 20/65), sepsis (n = 10/65), myocardial infarction/severe cardiac arrhythmia (n = 2/65), stroke (n = 2/65), as well as multiorgan failure, abdominal compartment syndrome, mesenteric and peripheral ischaemia (all n = 1/65). Multivariate analysis identified an operating time > 7 hours (p = .006) as an independent predictor of increased mortality. Freedom from re-intervention was 85%, 1 year survival was 80%, and overall survival was 75%. CONCLUSION: Open TAA(A) repair is a durable therapy for patients with CTD. Often being performed as revision surgery, it can be associated with relevant risks and should therefore be reserved for specialised centres. Staged procedures and thus reducing operating time, if applicable, should be preferred.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Keschenau PR, Kotelis D, Bisschop J, et al. Editor's Choice - Open Thoracic and Thoraco-abdominal Aortic Repair in Patients with Connective Tissue Disease. Eur J Vasc Endovasc Surg. 2017. PMID: 28916127. doi:10.1016/j.ejvs.2017.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。